Human metapneumovirus - what we know now

F1000Research

Volumn 7, Issue , 2018, Pages

  Williams, John ^a   Shafagati, Nazly ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute respiratory infection; Human metapneumovirus; Viral pneumonia

Indexed keywords

EPITOPE; HUMAN METAPNEUMOVIRUS VACCINE; IMMUNOGLOBULIN; INTERFERON; PROGRAMMED DEATH 1 RECEPTOR; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADAPTIVE IMMUNITY; AGE; ANTIVIRAL THERAPY; ASTHMA; AVIAN METAPNEUMOVIRUS; BRONCHITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD HOSPITALIZATION; CLINICAL FEATURE; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DISEASE MODEL; DRUG DEVELOPMENT; GENETIC DIFFERENCE; HOST RESISTANCE; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MIXED INFECTION; MORTALITY; NATURAL KILLER CELL; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PHYLOGENY; PNEUMONIA; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROEPIDEMIOLOGY; VIRAL CLEARANCE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 85041736377     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.12625.1     Document Type: Review

References (145)

1. Hamelin ME Abed Y Boivin G: Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis. 2004;38(7):983-90. 15034830 10.1086/382536
2. van den Hoogen BG de Jong JC Groen J: A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7(6):719-24. 11385510 10.1038/89098
3. Afonso CL Amarasinghe GK Bányai K: Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016;161(8):2351-60. 27216929 10.1007/s00705-016-2880-1 4947412 F1000 Recommendation
4. McDougall JS Cook JK: Turkey rhinotracheitis: preliminary investigations. Vet Rec. 1986;118(8):206-7. 3716162 10.1136/vr.118.8.206
5. Easton AJ Domachowske JB Rosenberg HF: Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev. 2004;17(2):390-412. 15084507 10.1128/CMR.17.2.390-412.2004 387412
6. Juhasz K Easton AJ: Extensive sequence variation in the attachment (G) protein gene of avian pneumovirus: evidence for two distinct subgroups. J Gen Virol. 1994;75(Pt 11):2873-80. 7964599 10.1099/0022-1317-75-11-2873
7. Seal BS: Matrix protein gene nucleotide and predicted amino acid sequence demonstrate that the first US avian pneumovirus isolate is distinct from European strains. Virus Res. 1998;58(1-2):45-52. 9879761 10.1016/S0168-1702(98)00098-7
8. Bäyon-Auboyer MH Arnauld C Toquin D: Nucleotide sequences of the F, L and G protein genes of two non-A/non-B avian pneumoviruses (APV) reveal a novel APV subgroup. J Gen Virol. 2000;81(Pt 11):2723-33. 11038385 10.1099/0022-1317-81-11-2723
9. Peret TC Boivin G Li Y: Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis. 2002;185(11):1660-3. 12023774 10.1086/340518
10. Boivin G Abed Y Pelletier G: Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis. 2002;186(9):1330-4. 12402203 10.1086/344319
11. Williams JV Harris PA Tollefson SJ: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350(5):443-50. 14749452 10.1056/NEJMoa025472 1831873
12. van den Hoogen BG Bestebroer TM Osterhaus AD: Analysis of the genomic sequence of a human metapneumovirus. Virology. 2002;295(1):119-32. 12033771 10.1006/viro.2001.1355
13. Biacchesi S Skiadopoulos MH Boivin G: Genetic diversity between human metapneumovirus subgroups. Virology. 2003;315(1):1-9. 14592754 10.1016/S0042-6822(03)00528-2
14. Piyaratna R Tollefson SJ Williams JV: Genomic analysis of four human metapneumovirus prototypes. Virus Res. 2011;160(1-2):200-5. 21740936 10.1016/j.virusres.2011.06.014 3347971
15. Biacchesi S Skiadopoulos MH Yang L: Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol. 2004;78(23):12877-87. 15542640 10.1128/JVI.78.23.12877-12887.2004 525014
16. Chang A Masante C Buchholz UJ: Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol. 2012;86(6):3230-43. 22238303 10.1128/JVI.06706-11 3302303 F1000 Recommendation
17. Derdowski A Peters TR Glover N: Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol. 2008;89(Pt 11):2698-708. 18931065 10.1099/vir.0.2008/004051-0 2876975
18. Fearns R Collins PL: Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol. 1999;73(7):5852-64. 10364337 112646
19. Ren J Wang Q Kolli D: Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS. J Virol. 2012;86(23):13049-61. 23015697 10.1128/JVI.01248-12 3497653
20. Masante C El Najjar F Chang A: The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity. J Virol. 2014;88(11):6423-33. 24672047 10.1128/JVI.02848-13 4093865
21. Thammawat S Sadlon TA Hallsworth PG: Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J Virol. 2008;82(23):11767-74. 18786997 10.1128/JVI.01208-08 2583676
22. El Najjar F Cifuentes-Muñoz N Chen J: Human metapneumovirus Induces Reorganization of the Actin Cytoskeleton for Direct Cell-to-Cell Spread. PLoS Pathog. 2016;12(9):e1005922. 27683250 10.1371/journal.ppat.1005922 5040343 F1000 Recommendation
23. Adamson P Thammawat S Muchondo G: Diversity in glycosaminoglycan binding amongst hMPV G protein lineages. Viruses. 2012;4(12):3785-803. 23242371 10.3390/v4123785 3528290
24. Cseke G Maginnis MS Cox RG: Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci U S A. 2009;106(5):1566-71. 19164533 10.1073/pnas.0801433106 2629439
25. Cox RG Livesay SB Johnson M: The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins. J Virol. 2012;86(22):12148-60. 22933271 10.1128/JVI.01133-12 3486500
26. Cox RG Mainou BA Johnson M: Human Metapneumovirus Is Capable of Entering Cells by Fusion with Endosomal Membranes. PLoS Pathog. 2015;11(12):e1005303. 26629703 10.1371/journal.ppat.1005303 4667933
27. Yang H He H Tan B: Human metapneumovirus uses endocytosis pathway for host cell entry. Mol Cell Probes. 2016;30(4):231-7. 27328610 10.1016/j.mcp.2016.06.003
28. Schowalter RM Smith SE Dutch RE: Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol. 2006;80(22):10931-41. 16971452 10.1128/JVI.01287-06 1642150
29. Herfst S Mas V Ver LS: Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J Virol. 2008;82(17):8891-5. 18596097 10.1128/JVI.00472-08 2519679
30. Lamb RA Kolakofsky D: Paramyxoviridae: The viruses and their replication.1996. Reference Source
31. Leyrat C Renner M Harlos K: Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure. 2014;22(1):136-48. 24316400 10.1016/j.str.2013.10.013 3887258 F1000 Recommendation
32. van den Hoogen BG Herfst S Sprong L: Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis. 2004;10(4):658-66. 15200856 10.3201/eid1004.030393 3323073
33. Kim JI Park S Lee I: Genome-Wide Analysis of Human Metapneumovirus Evolution. PLoS One. 2016;11(4):e0152962. 27046055 10.1371/journal.pone.0152962 4821609 F1000 Recommendation
34. de Graaf M Osterhaus AD Fouchier RA: Evolutionary dynamics of human and avian metapneumoviruses. J Gen Virol. 2008;89(Pt 12):2933-42. 19008378 10.1099/vir.0.2008/006957-0
35. Yang CF Wang CK Tollefson SJ: Human metapneumovirus G protein is highly conserved within but not between genetic lineages. Arch Virol. 2013;158(6):1245-52. 23385328 10.1007/s00705-013-1622-x 3669639
36. Haas LE Thijsen SF van Elden L: Human metapneumovirus in adults. Viruses. 2013;5(1):87-110. 23299785 10.3390/v5010087 3564111
37. Yang CF Wang CK Tollefson SJ: Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J. 2009;6:138. 19740442 10.1186/1743-422X-6-138 2753315
38. Skiadopoulos MH Biacchesi S Buchholz UJ: The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol. 2004;78(13):6927-37. 15194769 10.1128/JVI.78.13.6927-6937.2004 421687
39. Tang RS Mahmood K Macphail M: A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine. 2005;23(14):1657-67. 15705469 10.1016/j.vaccine.2004.10.009
40. MacPhail M Schickli JH Tang RS: Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol. 2004;85(Pt 6):1655-63. 15166450 10.1099/vir.0.79805-0
41. Williams JV Edwards KM Weinberg GA: Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis. 2010;201(12):1890-8. 20446850 10.1086/652782 2873123
42. Howard LM Edwards KM Zhu Y: Clinical Features of Human Metapneumovirus Infection in Ambulatory Children Aged 5-13 Years. J Pediatric Infect Dis Soc. 2017. 28369564 10.1093/jpids/pix012
43. Walsh EE Peterson DR Falsey AR: Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. 2008;168(22):2489-96. 19064834 10.1001/archinte.168.22.2489 2783624
44. Edwards KM Zhu Y Griffin MR: Burden of human metapneumovirus infection in young children. N Engl J Med. 2013;368(7):633-43. 23406028 10.1056/NEJMoa1204630 3662802
45. Williams JV Wang CK Yang CF: The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis. 2006;193(3):387-95. 16388486 10.1086/499274 1586246
46. Ebihara T Endo R Kikuta H: Seroprevalence of human metapneumovirus in Japan. J Med Virol. 2003;70(2):281-3. 12696118 10.1002/jmv.10391
47. Wolf DG Zakay-Rones Z Fadeela A: High seroprevalence of human metapneumovirus among young children in Israel. J Infect Dis. 2003;188(12):1865-7. 14673765 10.1086/380100
48. Pavlin JA Hickey AC Ulbrandt N: Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. J Infect Dis. 2008;198(6):836-42. 18680407 10.1086/591186 2648801
49. Lüsebrink J Wiese C Thiel A: High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin Vaccine Immunol. 2010;17(3):481-4. 20042516 10.1128/CVI.00398-09 2837972
50. Dunn SR Ryder AB Tollefson SJ: Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay. Clin Vaccine Immunol. 2013;20(10):1654-6. 23945161 10.1128/CVI.00750-12 3807191
51. Bosis S Esposito S Niesters HG: Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol. 2005;75(1):101-4. 15543589 10.1002/jmv.20243
52. Boivin G De Serres G Côté S: Human metapneumovirus infections in hospitalized children. Emerging Infect Dis. 2003;9(6):634-40. 12781001 10.3201/eid0906.030017 3000156
53. Peiris JS Tang WH Chan K: Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerging Infect Dis. 2003;9(6):628-33. 12781000 10.3201/eid0906.030009 3000155
54. van den Hoogen BG van Doornum GJ Fockens JC: Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis. 2003;188(10):1571-7. 14624384 10.1086/379200
55. McAdam AJ Hasenbein ME Feldman HA: Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004;190(1):20-6. 15195239 10.1086/421120
56. Anderson EJ Simões EA Buttery JP: Prevalence and Characteristics of Human Metapneumovirus Infection Among Hospitalized Children at High Risk for Severe Lower Respiratory Tract Infection. J Pediatric Infect Dis Soc. 2012;1(3):212-22. 26619409 10.1093/jpids/pis069
57. Aberle JH Aberle SW Redlberger-Fritz M: Human metapneumovirus subgroup changes and seasonality during epidemics. Pediatr Infect Dis J. 2010;29(11):1016-8. 20489673
58. Wei HY Tsao KC Huang CG: Clinical features of different genotypes/genogroups of human metapneumovirus in hospitalized children. J Microbiol Immunol Infect. 2013;46(5):352-7. 23022463 10.1016/j.jmii.2012.07.007
59. Schuster JE Khuri-Bulos N Faouri S: Human Metapneumovirus Infection in Jordanian Children: Epidemiology and Risk Factors for Severe Disease. Pediatr Infect Dis J. 2015;34(12):1335-41. 26372450 10.1097/INF.0000000000000892 4875771
60. van den Hoogen BG Osterhaus DM Fouchier RA: Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J. 2004;23(1 Suppl):S25-32. 14730267 10.1097/01.inf.0000108190.09824.e8
61. Williams JV Tollefson SJ Heymann PW: Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol. 2005;115(6):1311-2. 15940152 10.1016/j.jaci.2005.02.001 1476700
62. Jain S Williams DJ Arnold SR: Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-45. 25714161 10.1056/NEJMoa1405870 4697461 F1000 Recommendation
63. Self WH Williams DJ Zhu Y: Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis. 2016;213(4):584-91. 26180044 10.1093/infdis/jiv323 4721902 F1000 Recommendation
64. Chano F Rousseau C Laferrière C: Epidemiological survey of human metapneumovirus infection in a large pediatric tertiary care center. J Clin Microbiol. 2005;43(11):5520-5. 16272480 10.1128/JCM.43.11.5520-5525.2005 1287809
65. Kim YK Lee HJ: Human metapneumovirus-associated lower respiratory tract infections in korean infants and young children. Pediatr Infect Dis J. 2005;24(12):1111-2. 16371878
66. Klein MI Coviello S Bauer G: The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease. J Infect Dis. 2006;193(11):1544-51. 16652283 10.1086/503806
67. Madhi SA Ludewick H Abed Y: Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis. 2003;37(12):1705-10. 14689355 10.1086/379771
68. Boivin G De Serres G Hamelin ME: An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis. 2007;44(9):1152-8. 17407031 10.1086/513204
69. Williams JV Crowe JE Jr Enriquez R: Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis. 2005;192(7):1149-53. 16136455 10.1086/444392 1476781
70. García-García ML Calvo C Casas I: Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr Pulmonol. 2007;42(5):458-64. 17427899 10.1002/ppul.20597 F1000 Recommendation
71. Scheuerman O Barkai G Mandelboim M: Human metapneumovirus (hMPV) infection in immunocompromised children. J Clin Virol. 2016;83:12-6. 27522636 10.1016/j.jcv.2016.06.006 F1000 Recommendation
72. Spaeder MC Custer JW Bembea MM: A multicenter outcomes analysis of children with severe viral respiratory infection due to human metapneumovirus. Pediatr Crit Care Med. 2013;14(3):268-72. 23392374 10.1097/PCC.0b013e3182720fc7
73. Ampofo K Bender J Sheng X: Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008;122(2):229-37. 18676537 10.1542/peds.2007-3192
74. Seki M Yoshida H Gotoh K: Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae. Respir Med Case Rep. 2014;12:13-5. 26029528 10.1016/j.rmcr.2013.12.007 4061431
75. Esper F Martinello RA Boucher D: A 1-year experience with human metapneumovirus in children aged <5 years. J Infect Dis. 2004;189(8):1388-96. 15073675 10.1086/382482
76. Wyde PR Chetty SN Jewell AM: Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines. Antiviral Res. 2005;66(1):57-66. 15781133 10.1016/j.antiviral.2004.12.009
77. Williams JV Tollefson SJ Johnson JE: The cotton rat ( Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol. 2005;79(17):10944-51. 16103146 10.1128/JVI.79.17.10944-10951.2005 1193579
78. Zhang Y Niewiesk S Li J: Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse. Pathogens. 2014;3(3):633-55. 25438015 10.3390/pathogens3030633 4243432
79. Darniot M Petrella T Aho S: Immune response and alteration of pulmonary function after primary human metapneumovirus (hMPV) infection of BALB/c mice. Vaccine. 2005;23(36):4473-80. 15927322 10.1016/j.vaccine.2005.04.027
80. Kolli D Bataki EL Spetch L: T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol. 2008;82(17):8560-9. 18562525 10.1128/JVI.00699-08 2519650
81. Kukavica-Ibrulj I Hamelin ME Prince GA: Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol. 2009;83(3):1341-9. 19019962 10.1128/JVI.01123-08 2620891
82. Hamelin ME Prince GA Gomez AM: Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J Infect Dis. 2006;193(12):1634-42. 16703506 10.1086/504262
83. Hamelin M Yim K Kuhn KH: Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol. 2005;79(14):8894-903. 15994783 10.1128/JVI.79.14.8894-8903.2005 1168778 F1000 Recommendation
84. Zhang J Dou Y Wu J: Effects of N-linked glycosylation of the fusion protein on replication of human metapneumovirus in vitro and in mouse lungs. J Gen Virol. 2011;92(Pt 7):1666-75. 21450943 10.1099/vir.0.030049-0
85. Huck B Neumann-Haefelin D Schmitt-Graeff A: Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus. Respir Res. 2007;8:6. 17257445 10.1186/1465-9921-8-6 1794227
86. Hastings AK Erickson JJ Schuster JE: Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication. J Virol. 2015;89(8):4405-20. 25653440 10.1128/JVI.03275-14 4442394
87. Ren J Kolli D Deng J: MyD88 controls human metapneumovirus-induced pulmonary immune responses and disease pathogenesis. Virus Res. 2013;176(1-2):241-50. 23845303 10.1016/j.virusres.2013.06.014 3819944
88. Wen SC Tollefson SJ Johnson M: Acute clearance of human metapneumovirus occurs independently of natural killer cells. J Virol. 2014;88(18):10963-9. 24965465 10.1128/JVI.01558-14 4178848
89. Erickson JJ Gilchuk P Hastings AK: Viral acute lower respiratory infections impair CD8 + T cells through PD-1. J Clin Invest. 2012;122(8):2967-82. 22797302 10.1172/JCI62860 3408742
90. Darniot M Pitoiset C Petrella T: Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J Virol. 2009;83(7):3323-32. 19144706 10.1128/JVI.02198-08 2655584
91. Cseke G Wright DW Tollefson SJ: Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol. 2007;81(2):698-707. 17050599 10.1128/JVI.00844-06 1797435
92. Skiadopoulos MH Biacchesi S Buchholz UJ: Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology. 2006;345(2):492-501. 16300813 10.1016/j.virol.2005.10.016
93. Hamelin ME Couture C Sackett M: The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in mice. Antivir Ther. 2008;13(1):39-46. 18389897
94. Williams JV Chen Z Cseke G: A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol. 2007;81(15):8315-24. 17522220 10.1128/JVI.00106-07 1951312
95. Corti D Bianchi S Vanzetta F: Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature. 2013;501(7467):439-43. 23955151 10.1038/nature12442
96. Schuster JE Cox RG Hastings AK: A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus. J Infect Dis. 2015;211(2):216-25. 24864121 10.1093/infdis/jiu307 4342691
97. van den Hoogen BG Herfst S de Graaf M: Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J Gen Virol. 2007;88(Pt 4):1251-9. 17374769 10.1099/vir.0.82663-0
98. Falsey AR Hennessey PA Formica MA: Humoral immunity to human metapneumovirus infection in adults. Vaccine. 2010;28(6):1477-80. 20003919 10.1016/j.vaccine.2009.11.063 2864788
99. Alvarez R Harrod KS Shieh W: Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J Virol. 2004;78(24):14003-11. 15564507 10.1128/JVI.78.24.14003-14011.2004 533920
100. Erickson JJ Rogers MC Hastings AK: Programmed death-1 impairs secondary effector lung CD8 + T cells during respiratory virus reinfection. J Immunol. 2014;193(10):5108-17. 25339663 10.4049/jimmunol.1302208 4225166
101. Wen SC Schuster JE Gilchuk P: Lung CD8 + T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8 + T Cells. J Virol. 2015;89(17):8713-26. 26063431 10.1128/JVI.00670-15 4524081
102. Dinwiddie DL Harrod KS: Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation. Am J Respir Cell Mol Biol. 2008;38(6):661-70. 18218993 10.1165/rcmb.2007-0285OC
103. Bao X Kolli D Liu T: Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J Virol. 2008;82(16):8224-9. 18550666 10.1128/JVI.02584-07 2519579
104. Goutagny N Jiang Z Tian J: Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J Immunol. 2010;184(3):1168-79. 20042593 10.4049/jimmunol.0902750 2834787
105. Bao X Kolli D Ren J: Human metapneumovirus glycoprotein G disrupts mitochondrial signaling in airway epithelial cells. PLoS One. 2013;8(4):e62568. 23626834 10.1371/journal.pone.0062568 3633857
106. Guerrero-Plata A Casola A Suarez G: Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol. 2006;34(3):320-9. 16284360 10.1165/rcmb.2005-0287OC 2644197
107. Céspedes PF Gonzalez PA Kalergis AM: Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells. Immunology. 2013;139(3):366-76. 23374037 10.1111/imm.12083 3701183
108. Tan MC Battini L Tuyama AC: Characterization of human metapneumovirus infection of myeloid dendritic cells. Virology. 2007;357(1):1-9. 16959282 10.1016/j.virol.2006.08.004 1769550
109. Guerrero-Plata A Kolli D Hong C: Subversion of pulmonary dendritic cell function by paramyxovirus infections. J Immunol. 2009;182(5):3072-83. 19234204 10.4049/jimmunol.0802262 2865244
110. Le Nouën C Munir S Losq S: Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology. 2009;385(1):169-82. 19128816 10.1016/j.virol.2008.11.043 2668876
111. Le Nouën C Hillyer P Munir S: Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. PLoS One. 2010;5(11):e15017. 21124776 10.1371/journal.pone.0015017 2993941
112. Le Nouën C Hillyer P Winter CC: Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus. PLoS Pathog. 2011;7(6):e1002105. 21731495 10.1371/journal.ppat.1002105 3121884
113. Barber DL Wherry EJ Masopust D: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682-7. 16382236 10.1038/nature04444 F1000 Recommendation
114. Côté S Abed Y Boivin G: Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol. 2003;41(8):3631-5. 12904367 10.1128/JCM.41.8.3631-3635.2003 179772
115. Maertzdorf J Wang CK Brown JB: Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol. 2004;42(3):981-6. 15004041 10.1128/JCM.42.3.981-986.2004 356857
116. Klemenc J Asad Ali S Johnson M: Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus. J Clin Virol. 2012;54(4):371-5. 22677006 10.1016/j.jcv.2012.05.005 3412361
117. Popowitch EB O'Neill SS Miller MB: Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses. J Clin Microbiol. 2013;51(5):1528-33. 23486707 10.1128/JCM.03368-12 3647947
118. Tollefson SJ Cox RG Williams JV: Studies of culture conditions and environmental stability of human metapneumovirus. Virus Res. 2010;151(1):54-9. 20380856 10.1016/j.virusres.2010.03.018 2894476
119. Wyde PR Chetty SN Jewell AM: Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 2003;60(1):51-9. 14516921 10.1016/S0166-3542(03)00153-0
120. Hamelin M Prince GA Boivin G: Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother. 2006;50(2):774-7. 16436743 10.1128/AAC.50.2.774-777.2006 1366914
121. Shah DP Shah PK Azzi JM: Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. 2016;379(1):100-6. 27260872 10.1016/j.canlet.2016.05.035 4935561 F1000 Recommendation
122. Herfst S de Graaf M Schrauwen EJ: Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters. J Gen Virol. 2008;89(Pt 7):1553-62. 18559924 10.1099/vir.0.2008/002022-0
123. Herfst S Schrauwen EJ de Graaf M: Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Vaccine. 2008;26(33):4224-30. 18585830 10.1016/j.vaccine.2008.05.052
124. Buchholz UJ Biacchesi S Pham QN: Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol. 2005;79(11):6588-97. 15890897 10.1128/JVI.79.11.6588-6597.2005 1112115
125. Tedcastle AB Fenwick F Robinson MJ: Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein. J Med Virol. 2014;86(4):547-57. 24009128 10.1002/jmv.23731 F1000 Recommendation
126. Zhang Y Wei Y Zhang X: Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase. J Virol. 2014;88(19):11411-29. 25056882 10.1128/JVI.00876-14 4178811 F1000 Recommendation
127. Wei Y Zhang Y Cai H: Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol. 2014;88(8):4338-52. 24478423 10.1128/JVI.03491-13 3993731 F1000 Recommendation
128. Pham QN Biacchesi S Skiadopoulos MH: Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J Virol. 2005;79(24):15114-22. 16306583 10.1128/JVI.79.24.15114-15122.2005 1316028
129. Mok H Tollefson SJ Podsiad AB: An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol. 2008;82(22):11410-8. 18786987 10.1128/JVI.01688-08 2573258
130. Bates JT Pickens JA Schuster JE: Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine. 2016;34(7):950-6. 26772634 10.1016/j.vaccine.2015.12.045 4731299
131. Russell CJ Jones BG Sealy RE: A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge. Virology. 2017;509:60-6. 28605636 10.1016/j.virol.2017.05.021 5551427 F1000 Recommendation
132. Talaat KR Karron RA Thumar B: Experimental infection of adults with recombinant wild-type human metapneumovirus. J Infect Dis. 2013;208(10):1669-78. 23908489 10.1093/infdis/jit356 3805236
133. Karron RA San Mateo J Wanionek K: Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children. J Pediatric Infect Dis Soc. 2017. 28444226 10.1093/jpids/pix006 F1000 Recommendation
134. Fulginiti VA Eller JJ Sieber OF: Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969;89(4):435-48. 4305199 10.1093/oxfordjournals.aje.a120956
135. Kapikian AZ Mitchell RH Chanock RM: An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969;89(4):405-21. 4305197 10.1093/oxfordjournals.aje.a120954
136. Kim HW Canchola JG Brandt CD: Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89(4):422-34. 4305198 10.1093/oxfordjournals.aje.a120955
137. Prince GA Jenson AB Hemming VG: Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol. 1986;57(3):721-8. 2419587 252798
138. Murphy BR Sotnikov AV Lawrence LA: Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine. 1990;8(5):497-502. 2251875 10.1016/0264-410X(90)90253-I
139. Hamelin M Couture C Sackett MK: Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. J Gen Virol. 2007;88(Pt 12):3391-400. 18024909 10.1099/vir.0.83250-0
140. Yim KC Cragin RP Boukhvalova MS: Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine. 2007;25(27):5034-40. 17543425 10.1016/j.vaccine.2007.04.075 1937335
141. de Swart RL van den Hoogen BG Kuiken T: Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine. 2007;25(51):8518-28. 17996988 10.1016/j.vaccine.2007.10.022
142. Cox RG Erickson JJ Hastings AK: Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model. J Virol. 2014;88(11):6368-79. 24672031 10.1128/JVI.00332-14 4093842
143. Lévy C Aerts L Hamelin MÈ: Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice. Vaccine. 2013;31(25):2778-85. 23583815 10.1016/j.vaccine.2013.03.051
144. Herd KA Mahalingam S Mackay IM: Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol. 2006;80(4):2034-44. 16439559 10.1128/JVI.80.4.2034-2044.2006 1367143
145. Li X Guo L Kong M: Design and Evaluation of a Multi-Epitope Peptide of Human Metapneumovirus. Intervirology. 2015;58(6):403-12. 27096202 10.1159/000445059